A new liposomal liver-specific contrast agent for CT: first human phase-I clinical trial assessing efficacy and safety
In this first clinical trial liposome-encapsulated iodixanol, CT particles (CTP) were studied. The aims of the present trial were to assess the efficacy of CTP in CT and to determine the safety of different doses of CTP. A total of 47 healthy volunteers were enrolled in the present study. The CTP wa...
Saved in:
Published in | European radiology Vol. 11; no. 4; pp. 698 - 704 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Springer Nature B.V
01.01.2001
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!